Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hodgkin's lymphoma].

V Vecchi

    La Pediatria Medica E Chirurgica : Medical and Surgical Pediatrics
    |March 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Pediatric Hodgkin

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    MRI in acute intermittent maple syrup urine disease.

    Neurology·2004
    Same author

    A case of juvenile myelomonocytic leukemia presenting with a B-lymphoblastic immunophenotype.

    Haematologica·2001
    Same author

    Treatment of childhood acute lymphoblastic leukemia. Long-term results of the AIEOP-ALL 87 study.

    Haematologica·2001
    Same author

    Role of CCR5 chemokine receptor gene in vertical human immunodeficiency virus type 1 transmission and disease progression.

    The Pediatric infectious disease journal·1998
    Same author

    Risk-directed therapy for childhood acute lymphoblastic leukemia. Results of the Associazione Italiana Ematologia Oncologia Pediatrica '82 studies.

    Cancer·1993
    Same author

    Treatment of pediatric Hodgkin disease tailored to stage, mediastinal mass, and age. An Italian (AIEOP) multicenter study on 215 patients.

    Cancer·1993

    Area of Science:

    • Pediatric Oncology
    • Cancer Treatment Advances

    Background:

    • Significant medical progress has improved cure rates for childhood cancers, including Hodgkin's disease.
    • Long-term data show high survival and disease-free rates but highlight treatment-related toxicities like growth issues, sterility, and secondary cancers.

    Purpose of the Study:

    • To identify a treatment strategy for pediatric Hodgkin's disease that maintains high survival and disease-free rates.
    • To minimize treatment-related complications in children with Hodgkin's disease.

    Main Methods:

    • Combination therapy using low-dose irradiation and chemotherapy (alternating MOPP/ABVD non-cross-resistant drug combinations).

    Main Results:

    • This therapeutic approach shows optimistic cure rates with reduced morbidity.

    Related Experiment Videos

  • High actuarial survival rates (90% at 5 years, 80% at 10 years, 70% at 15 years) and freedom from relapse rates (75% at 5 years, 66% at 10 and 15 years) have been observed.

    • Conclusions:

    • The combination of low-dose irradiation and MOPP/ABVD chemotherapy offers a promising treatment for pediatric Hodgkin's disease with improved outcomes and reduced side effects.
    • Future research should focus on defining the risk/benefit ratio of this therapy and the role of surgical staging in pediatric patients.